Loading
NASDAQHealthcareMedical - Healthcare Information Services
Latest quote
$13.9601
−$0.4199 · -2.92%
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
Regular session
$13.9601
−$0.4199 · -2.92%
Regular session · ET · Market data may be delayed.
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
Day range
Current $13.9601
52-week range
Current $13.9601
Regular session · ET · Market data may be delayed.
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
Day range
Current $13.9601
52-week range
Current $13.9601
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | 50.51M USD | 27.17M USD | 13.78M USD |
| Cost of goods sold | 12.47M USD | 7.12M USD | 3.88M USD |
| Gross profit | 38.04M USD | 20.05M USD | 9.9M USD |
| Research and development | 17.02M USD | 14.3M USD | 7.4M USD |
| Selling, general, and administrative | 51.6M USD | 29.87M USD | 21.1M USD |
| Operating expenses | 68.61M USD | 44.17M USD | 28.49M USD |
| Interest income | 2.7M USD | 1.33M USD | 334K USD |
| Interest expense | 1.43M USD | 1.32M USD | 641K USD |
| Depreciation and amortization | 281K USD | 145K USD | 136K USD |
| Operating income | −30.57M USD | −24.12M USD | −18.59M USD |
| Net income | −29.63M USD | −24.26M USD | −18.9M USD |
Company facts updated Oct 8, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Limited analyst sample: 3 ratings. Interpret the distribution with caution.
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Russell 2000 ETFIWM3.12M0.00%78.56B USD0.19%$274.86-1.02%
Vanguard Morningstar Total Stock Market ETFVTI2.58M0.00%2.3T USD0.03%$379.47-0.41%
Vanguard Extended Market ETFVXF1.27M0.00%95.4B USD0.05%$231.36-0.91%
Vanguard Russell 2000 ETFVTWO796.09K0.00%18B USD0.06%$110.99-1.09%
iShares Russell 2000 Growth ETFIWO636.88K0.00%14.25B USD0.24%$350.65-1.33%
EA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSM460K0.39%116.75M USD0.73%$15.77-1.25%
iShares Micro-Cap ETFIWC386.19K0.03%1.33B USD0.60%$181-1.29%
Russell Investments Exchange Traded Funds - Russell Investments US Small Cap Equity ETFRUSC75.78K0.09%81.07M USD0.69%$35.9882-0.64%iShares Russell 2000 ETFIWMVanguard Morningstar Total Stock Market ETFVTIVanguard Extended Market ETFVXFVanguard Russell 2000 ETFVTWOiShares Russell 2000 Growth ETFIWOEA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSMiShares Micro-Cap ETFIWCRussell Investments Exchange Traded Funds - Russell Investments US Small Cap Equity ETFRUSCAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
